Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Psychiatry
•
Addiction Psychiatry
How do you approach patients using off-label GLP-1 agonists for alcohol or opioid cravings?
Related Questions
How do you engage and approach a patient presenting with psychotic symptoms who has demonstrated a pattern of malingering and also has polysubstance use disorder?
What are the best initial treatments for unprescribed stimulant use in patients are using stimulants periodically to improve occupational or academic functioning?
What are your preferred non-benzodiazepine therapies for the hyperactive/agitated phase of methamphetamine withdrawal, both in the hospital and in the office?
How do you counsel patients regarding risks of cannabis use?
How do you support recovery in patients with MDD and AUD experiencing anhedonia and social isolation after losing alcohol-based social networks?
When do you recommend acamprosate vs. naltrexone for medication-assisted therapy in alcohol use disorder?
What precautions should be taken when discharging a patient from the medical setting on new medication assisted therapy for alcohol use disorder?
What are your perspectives on using GLP-1 agonists as a primary or adjunctive treatment in psychiatric care?
What medications have you found helpful in the treatment of stimulant use disorder?
How do you approach the use of benzodiazepines in patients with chronic medical illnesses that may be susceptible to respiratory compromise (e.g., CHF, COPD, ILD)?
